Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures

Maribeth C Lovegrove1, Nina J Weidle2, Andrew I Geller1

  • 1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Insights

Unsupervised medication exposures in young children led to fewer emergency visits from 2009-2020, with significant declines in benzodiazepine and opioid exposures. Continued prevention efforts are crucial for further reductions in these pediatric poisonings.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health Surveillance
  • Toxicology

Background:

  • Unsupervised medication exposures in children under 5 years old historically led to increased emergency department (ED) visits and hospitalizations.
  • Prevention initiatives were implemented to address this public health concern.

Purpose of the Study:

  • To analyze trends in ED visits for unsupervised medication exposures among young children (≤5 years) in the U.S. from 2009 to 2020.
  • To identify specific medications associated with changes in exposure trends.

Main Methods:

  • Utilized nationally representative data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project.
  • Analyzed data from 2009 to 2020 to assess overall and medication-specific trends in ED visits for unsupervised exposures in children aged ≤5 years.
  • Data analysis was conducted in 2022.

Main Results:

  • An estimated 677,968 ED visits for unsupervised medication exposures occurred in children ≤5 years from 2009-2020.
  • Significant declines were observed for benzodiazepines, opioids, and over-the-counter cough/cold medications and acetaminophen.
  • Increases in exposures were noted for over-the-counter herbal/alternative remedies, particularly melatonin.

Conclusions:

  • Estimated ED visits and hospitalizations for unsupervised medication exposures decreased between 2009 and 2020, coinciding with prevention efforts.
  • While overall trends improved, specific medication exposures require targeted prevention strategies.
  • Continued focused interventions are necessary to further reduce unsupervised medication exposures in young children.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
792
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
917
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K